About this item:
329 Views | 245 Downloads
Author Notes:
Correspondence: Karl W Boehme, Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, 4301 West Markham Street, No. 511, Little Rock, AR 72205, USA, Tel +1 501 686 5189, Fax +1 501 686 5359, Email kwboehme@uams.edu Bernardo A Mainou, Department of Pediatrics, Emory University School of Medicine, ECC 564, 2015 Uppergate Drive, Atlanta, GA 30322, USA, Tel +1 404 727 1605, Fax +1 404 727 9223, Email bernardo.mainou@emory.edu
The authors report no conflicts of interest in this work.
Subjects:
Research Funding:
This research was supported by Public Health Award R01 AI118801 (K.W.B.), Children’s Healthcare of Atlanta, the Emory Children’s Pediatric Center, and Winship Cancer Institute IRG-14-188-01 from the American Cancer Society (B.A.M.).
Additional support was provided by the Center for Microbial Pathogenesis and Host Inflammatory Response (P20 GM103625).
Keywords:
- cancer
- cell death
- immunotherapy
- interferon
- virotherapy
Current understanding of reovirus oncolysis mechanisms.
Abstract:
Copyright information:
© 2018 Phillips et al. This work is published and licensed by Dove Medical Press Limited
